Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNSF.L Regulatory News (NSF)

  • There is currently no data for NSF

Trading Update

23 Feb 2021 07:00

RNS Number : 9602P
Non-Standard Finance PLC
23 February 2021
 

Non-Standard Finance plc

('NSF', the 'Company' or the 'Group')

23 February 2021

 

Trading update

The Board of Non-Standard Finance has this morning issued the following trading update. The audit of our 2020 results is now underway and the information given below is unaudited, pending the completion of the audit process.

Branch-based lending - Whilst there was a strong pick-up in loan volume during August, September and October 2020 with new cash issued running at c.£10 million per month that stabilised the loan book, the subsequent tiered lockdowns, which were particularly severe in our customer heartland, reduced lending volumes in November and December. As a result, the net loan book at 31 December 2020 was c.20% lower than at the end of 2019. Whilst a consequence of the COVID-19 pandemic has been a significant increase in impairment and provisions, it has been most encouraging that the loans written since the start of the pandemic have performed better than our historical average and in the second half of 2020 we also saw an improvement in the collection performance of the COVID-flagged book. This robust performance of new lending illustrates the strength of our face-to-face lending model and augurs well for a return to strong sector growth once the economy begins to open up again. 

Home credit - Loans at Home also experienced a significant uplift in loan volume during the second half of 2020 with new cash issued running at c.£5m per month. Although growth in lending volume continued in November and December due to the normal seasonal pattern, this was down by a third versus 2019 as a result of the tiered lockdowns and the closure of retail in December 2020. Collections improved on the whole loan book in the second half and the number of COVID-19 flagged customers had reduced to less than 1% at the year-end with the result that impairment as a percentage of revenue in 2020 was significantly lower than in 2019. This strong collections performance, in conjunction with lower lending meant that the net loan book ended the year down by a third versus 2019. We expect to see a significant increase in demand once the economy is opened up as our customers resume their normal lifestyle. There may also be opportunities to take advantage of some competitors contracting their business in this sector.

Guarantor loans - Following the FCA's review of the Group's guarantor loans division as part of a wider review of the guarantor loan sector, resulting in a £16m provision for redress announced in our 2020 half year results, lending volumes were minimal in the second half of 2020. Economically, the younger customer base has been harder hit by the pandemic than our other two divisions and calls on guarantors have been constrained due to the pandemic, resulting in a marked increase in impairment. Collections nevertheless remained robust during the second half of 2020 with the result that the net loan book reduced by c.40% versus the prior year. We are working hard on the redress methodology and hope to have concluded the process with the FCA early in the second quarter.

Group - Branch-based lending and home credit delivered a solid trading performance during the second half of 2020 in what were extremely challenging circumstances and overall, the Group's combined net loan book declined by c.27% versus the previous year.

Liquidity and funding

The Group has continued to operate within its financial covenants. The combination of lower levels of lending with a solid collections performance meant that as at 31 December, 2020 cash at bank had increased to £78m and gross borrowings were £330m.

Capital raise

The Group now needs to strengthen the balance sheet by raising sufficient new equity capital to support future growth, avoid future covenant breaches and to address the material uncertainties regarding going concern. The Board has therefore commenced work on a substantial capital raise with the support of Alchemy, its largest shareholder with a view to completing this in the second quarter of 2021. Once completed, the Group will be in a strong position to take advantage of what it believes to be an exceptional market opportunity in the non-standard sector.

 

For more information:

 

Non-Standard Finance plc

Peter Reynolds, Director, IR and Communications

 

+44 (0) 20 3869 9020

 

Maitland/AMO

Neil Bennett

Andy Donald

Finlay Donaldson

 

+44 (0) 20 7379 5151

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUURRRAAUUUUR
Date   Source Headline
31st Oct 20174:40 pmRNSSecond Price Monitoring Extn
31st Oct 20174:35 pmRNSPrice Monitoring Extension
20th Oct 201712:06 pmRNSDirector/PDMR Shareholding
9th Oct 20179:57 amRNSHolding(s) in Company
28th Sep 20173:39 pmRNSGeorge Banco receives full FCA authorisation
19th Sep 20172:25 pmRNSHolding(s) in Company
23rd Aug 20177:00 amRNSNotification of Transactions of PDMRs
17th Aug 20173:42 pmRNSCompletion of acquisition of George Banco
11th Aug 20171:13 pmRNSHardman Research: H117 Delivering growth options
4th Aug 20177:00 amRNSDirector/PDMR Shareholding
3rd Aug 20177:01 amRNSAcquisition of George Banco, £225m term loan & RCF
3rd Aug 20177:00 amRNSUnaudited half year results to 30 June 2017
26th Jul 20173:01 pmRNSNotice of Results
25th Jul 20174:35 pmRNSPrice Monitoring Extension
5th Jun 20177:00 amRNSAppointment of joint broker
17th May 20177:00 amRNSLoans at Home receives full FCA authorisation
10th May 20172:52 pmRNSHolding(s) in Company
9th May 201712:50 pmRNSResult of AGM
9th May 20177:00 amRNSAGM Trading update
4th May 20172:02 pmRNSDirectorate Change
4th May 201711:03 amRNSHolding(s) in Company
3rd May 20171:51 pmRNSHolding(s) in Company
3rd May 20178:39 amRNSHolding(s) in Company
19th Apr 20174:52 pmRNSHolding(s) in Company
18th Apr 201712:41 pmRNSHolding(s) in Company
10th Apr 20172:55 pmRNSAnnual Financial Report
17th Mar 20177:00 amRNSExtension of Existing Bank Facilities
15th Mar 20173:46 pmRNSNotification under Listing Rule 9.6.14(2)
13th Mar 201710:42 amRNSHardman Research: Branching Out Invest Accelerated
3rd Mar 201712:45 pmRNSTimetable for final dividend
3rd Mar 20177:00 amRNSFinal Results
28th Feb 20178:00 amRNSMarket developments in home-collected credit
17th Jan 20177:00 amRNSPre-Close Trading Update
13th Jan 20174:40 pmRNSSecond Price Monitoring Extn
13th Jan 20174:35 pmRNSPrice Monitoring Extension
19th Dec 20169:30 amRNSDirectorate Change
1st Dec 20169:25 amRNSDirector/PDMR Shareholding
1st Dec 20169:25 amRNSDirector/PDMR Shareholding
29th Nov 20168:58 amRNSFCA review of high-cost credit and overdrafts
15th Nov 20164:25 pmRNSDirector/PDMR Shareholding
11th Nov 201610:05 amRNSHardman Research: "Carpe Diem"
10th Nov 20164:40 pmRNSSecond Price Monitoring Extn
10th Nov 20164:35 pmRNSPrice Monitoring Extension
1st Nov 20167:00 amRNSInvestor day and trading update
31st Oct 201611:10 amRNSDirectorate Change
27th Oct 201611:55 amRNSHolding(s) in Company
5th Sep 201611:48 amRNSTotal Voting Rights
4th Aug 201612:07 pmRNSSecond Price Monitoring Extn
4th Aug 201612:02 pmRNSPrice Monitoring Extension
3rd Aug 20167:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.